Cytokinetics (CYTK) EBITDA Margin (2010 - 2026)
Cytokinetics' EBITDA Margin came in at -343.67% for Q3 2026, up 8131.33 percentage points from -8475.00% a year earlier and up 269.59 percentage points from the prior quarter.
Powered by 
Analysis
Cytokinetics (CYTK) EBITDA Margin (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Cytokinetics reported EBITDA Margin of -613.22%, up 47.26 percentage points year-over-year; for FY2025, it came in at -683.94%.
- EBITDA Margin carries a five-year change of -518.95 percentage points (FY2020 to FY2025).
- Going back by year, EBITDA Margin was -6431.78% in FY2023 (-6095.17 pp), -336.61% in FY2022 (-75.29 pp) and -261.31% in FY2021 (-96.32 pp).
- The Q3 2026 figure represents the highest quarterly EBITDA Margin since Q2 2025.
- Year-over-year, EBITDA Margin increased in six of the last eight quarters, with an average year-over-year change of +12550.68 percentage points.
- The fastest year-over-year change in EBITDA Margin over five years came in Q2 2025 (a gain of 51148.07 percentage points), and the weakest in Q2 2024 (a drop of 37448.44 percentage points).
- Business Quant data shows CYTK's EBITDA Margin at -613.27% (Q2 2026), -931.23% (Q1 2026) and -988.48% (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 54.65% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 40.75% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 42.49% |
| 10 | Cytokinetics | 7.81 Bn | 3.81 Bn | 47.10 Mn | -343.67% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -343.67% |
| Jun 30, 2026 | -613.27% |
| Mar 31, 2026 | -931.23% |
| Dec 31, 2025 | -988.48% |
| Sep 30, 2025 | -8,475.00% |
| Jun 30, 2025 | -163.58% |
| Mar 31, 2025 | -9,710.64% |
| Dec 31, 2024 | -911.05% |
| Sep 30, 2024 | -29,889.85% |
| Jun 30, 2024 | -51,311.65% |
| Mar 31, 2024 | -14,838.80% |
| Dec 31, 2023 | -7,241.81% |
| Sep 30, 2023 | -31,854.76% |
| Jun 30, 2023 | -13,863.21% |
| Mar 31, 2023 | -2,658.25% |
| Dec 31, 2022 | -6,406.34% |
| Sep 30, 2022 | -4,255.79% |
| Jun 30, 2022 | -10.64% |
| Mar 31, 2022 | -6,665.16% |
| Dec 31, 2021 | -37.72% |
API Access
Cytokinetics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CYTK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "CYTK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CYTK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();